AMZN
Amazon.com, Inc.
AMZN has the edge over SN overall, supported by stronger valuation and stronger modeled upside.
SN
SharkNinja, Inc.
SN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
SN's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SN in the historical PE scenario, which offers more potential upside but is not a forecast.
SN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 26x | $155 | -29% |
| Forward | 30x | $220 | — |
| Fair | 36x | $214 | -2.8% |
| Current | 37x | $220 | — |
| Expensive | 55x | $329 | +50% |
Historical ranges are pointers, not guarantees.
SN's PE is in its fair range at 37x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
SN has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SN on earnings, with stronger typical year-over-year growth.
SN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.26 | +22% |
| Q3 2026 | $5.96 | +47% |
| Q2 2026 | $4.90 | +34% |
| Q1 2026 | $4.96 | +57% |
| Q4 2025 | $4.94 | +59% |
| Q3 2025 | $4.05 | +59% |
| Q2 2025 | $3.66 | +110% |
| Q1 2025 | $3.16 | +134% |
| Q4 2024 | $3.11 | +159% |
SN's earnings per share have climbed steadily: $5.96 over the past year, up 47% from the year before, and higher year over year for 11 quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
SN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +21% |
| Q2 2026 | $1.8B | +22% |
| Q1 2026 | $1.4B | +16% |
| Q4 2025 | $2.1B | +18% |
| Q3 2025 | $1.6B | +14% |
| Q2 2025 | $1.4B | +16% |
| Q1 2025 | $1.2B | +15% |
| Q4 2024 | $1.8B | +30% |
SN has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +5.9 points |
| Q2 2026 | 10% | -1.5 points |
| Q1 2026 | 12% | -0.2 points |
| Q4 2025 | 16% | +4.9 points |
| Q3 2025 | 17% | +3.9 points |
| Q2 2025 | 12% | +3.3 points |
| Q1 2025 | 12% | -2.8 points |
| Q4 2024 | 11% | +4.2 points |
SN has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$209.7M | -343% |
| Q2 2026 | $382.6M | +$419.2M |
| Q1 2026 | -$190.2M | -$98.5M |
| Q4 2025 | $523.3M | +19% |
| Q3 2025 | $86.2M | +$151.2M |
| Q2 2025 | -$36.5M | +$57.5M |
| Q1 2025 | -$91.7M | -639% |
| Q4 2024 | $441.4M | +237% |
SN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +14.5K shares |
| 1 year | -0.4% | -598K shares |
| 3 years | +1.5% | +2.1M shares |
SN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $100.7M |
| Q1 2026 | $18.5M |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q2 2025 | $788,000 |
| Q1 2025 | $48.4M |
| Q4 2024 | $11.4M |
SN spent $170M buying back its own shares over the past year, up 175% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.8x | Very low |
SN has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 91.2 | Overbought |
SN's weekly RSI is 74 (overbought) and its Stochastic is 91 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over SN on valuation relative to its sector.
SN PE vs Consumer Cyclical Sector
| Metric | SN | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 18x | 105% above |
| PE % | 52 | 33 | 19 pts above |
SN is trading at 37x earnings, a 105% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
SN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus SN above 4 of 4.
SN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $197.4 | 12% above |
| 20 week MA | $179.5 | 23% above |
| 50 week MA | $142.3 | 55% above |
| 100 week MA | $120.7 | 82% above |
SN is in an uptrend: it's above all four of its weekly moving averages, and 82% above its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
SN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $26.9 | $51.2 | +90% |
| 2024 | $51.2 | $97.3 | +90% |
| 2025 | $97.3 | $114.0 | +17% |
| 2026 YTD | $114.0 | $220.1 | +93% |
SN has the edge over AMZN on returns for 2026, with the stronger performance.